AstraZeneca announced positive high-level data from the HIMALAYA Phase III trial of a single, high priming dose of tremelimumab plus Imfinzi (durvalumab) in patients with unresectable hepatocellular carcinoma...
The U.S. Food and Drug Administration agreed to place Regeneron Pharmaceuticals Inc.'s Biologics License Application (BLA) for the Covid-19 drug REGEN-COV under priority review with a target...
There is immense interest in understanding whether potentially protective SARS-CoV-2 antibodies are provided to the baby via breast milk. This is what we know so far.
Europe's drug regulator started a real-time review of AstraZeneca's antibody-based Covid-19 therapy, the first protective shot other than vaccines against coronavirus.
NIH-Backed Study Finds Moderna, Pfizer Boosters Work Best After months of dithering about the potential safety risks of mixing and matching various approved COVID vaccines, a...
People who received Johnson & Johnson's Covid-19 vaccine will have a stronger neutralizing antibody response if they get an mRNA shot as the second dose, Axios...
In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
Merck To Double Production Of 'Breakthrough' COVID Drug As Nations Line Up To Buy Despite safety concerns raised by multiple scientists, Merck is signing deals with...
When IGM Biosciences made its public debut two years ago, the S-1 pitch was heavily centered on how its engineered IgM antibodies could make potent cancer...
As expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral The post Merck files pill for milder COVID,...
Merck & Co. Inc. (NYSE: MRK) announced that it had sought the Food and Drug Administration’s permission to use its investigational antiviral tablet in the treatment...
Less than a week after AstraZeneca made its pitch to the FDA for emergency use of its monoclonal antibody combo for Covid-19 prophylaxis, the British pharma...
COVID-19 Cases, Hospitalizations Plummet In Southern US, Rise In Northern States Authored by Zachary Stieber via The Epoch Times (emphasis ours), COVID-19 metrics in southern states...
The Delta variant of the coronavirus does not appear to cause more severe disease in children than earlier forms of the virus, a UK study suggests....
CDC Head Says She "Can't Predict" When COVID Will End; Blames Unvaccinated Speaking to a gathering of journalists and academics organized by the Health Coverage Fellowship,...
Biotech stocks to note amid today's stock market gains. The post 4 Biotech To Watch As Pfizer Seeks FDA Approval For Child Vaccines appeared first on...
So, you think the “Green New Deal” is dead? Think again. Energy prices are soaring not only in the United States but in Europe and Asia...
The flexibility of emergency use authorizations, and allowing the FDA to accept more uncertainty during the pandemic so far, has ultimately aided its response to Covid-19,...
“Winter is coming” – could it fuel another surge in COVID-19 cases in the United States? Morgan Stanley’s biotech analyst Matthew Harrison thinks so. But on...
Antibodies Persist For More Than A Year After COVID-19 Infection, Study Finds Authored by Ivan Pentchoukov via The Epoch Times (emphasis ours), The immune systems of...
To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections,...
Recalling the founding of Genetic Systems, a monoclonal antibody company that helped incite the biotech revolution. The post Those Were the Early Days My Friend, We...
Paradigm changes arise from thinking outside the box about new directions or approaches to science and are always initially met with great skepticism. They require determined...
First Responders: From Heroes To Zeroes Authored by Grace Curley via SpectatorWorld.com, The rule-makers are not as concerned with medicine, science or health as they purport...
Merck said data from the Phase III MOVe-OUT trial showed that 28 of 385 patients (7.3%) who received molnupiravir were either hospitalized or died through Day...
The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed...
Texas Acquires COVID-19 Monoclonal Antibodies, Bypassing Biden HHS Limits: Governor Authored by Jack Phillips via The Epoch Times, Texas Gov. Greg Abbott on Monday announced his state has obtained...
This thought leadership series has been paid and developed by Kite, a Gilead Company. This Blood Cancer Awareness The post Blood Cancer UK: Hopes for our...
Pfizer has joined the ranks of drugmakers looking to combine seasonal vaccines, revealing new data on Wednesday suggesting its freshly approved 20-valent pneumococcal vaccine can be...
A month after revealing that its monoclonal antibody combination was 77% effective at preventing symptomatic Covid-19 compared to placebo, AstraZeneca says it’s headed to the FDA....